- Home
- SANA vs PRGO Comparison
SANA vs PRGO Comparison
Compare SANA & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SANA | PRGO |
|---|---|---|
| Founded | 2018 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | 8100 |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SANA | PRGO |
|---|---|---|
| Price | $3.22 | $10.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $7.60 | ★ $19.33 |
| AVG Volume (30 Days) | 2.6M | ★ 3.8M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.98% |
| EPS Growth | ★ 17.24 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.42 | $9.23 |
| 52 Week High | $6.55 | $28.44 |
Technical Indicators
Market Signals| Indicator | SANA | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 51.13 |
| Support Level | $3.16 | $9.24 |
| Resistance Level | $3.36 | $15.08 |
| Average True Range (ATR) | 0.22 | 0.54 |
| MACD | 0.06 | 0.29 |
| Stochastic Oscillator | 72.67 | 77.46 |
Price Performance
Historical ComparisonAbout SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.